PhasenoGet started →

Spec sheet 002 / Step 2

From lab to review: how the pieces fit before a product reaches regulators

Before a Phase 1 study ever starts, years of lab work come first. After Phase 3, a formal review follows. Here is the whole arc in short form.

Sheet002TopicStep 2
Read time6 minReviewedNov 2026

Summary

  1. Laboratory and animal studies come first and help decide whether human studies are reasonable.
  2. Regulators review results from the human studies before a product is approved.
  3. Approval is a decision about benefits and risks, and monitoring continues afterward.

Section 1.0

Before people

Researchers study an idea in the laboratory and, where required, in animals. These steps look at how something behaves and at early signs of safety, and they shape what the first human study looks like.

Section 2.0

Asking permission

In the United States, sponsors submit plans to the FDA before human studies of many products begin, and independent review boards look at studies that involve people.

Section 3.0

The review

After the later phases, a sponsor can submit its results for review. Regulators weigh the evidence on benefits and risks and decide whether to approve it and how it should be labeled.

Section 4.0

Not the end

After approval, safety reporting continues. This is a summary for general understanding, and each product’s path differs.

Phaseno is an information website, not a medical provider, research sponsor, study site, or recruiter. We do not treat patients, enroll volunteers, rank studies, or pass your details to sponsors, sites, or recruiters. The guides are general information, not medical, legal, or financial advice.

Output: clearer next steps.

Get started